Home
Conditions
Lymphoma, B-Cell

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

1,618 public trials 340 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Completed

Investigation of Endemic and Emerging Diseases in Populations of Homeless Households in Marseille.

NCT02819128

Conditions: Burkitt Lymphoma, DNA Virus Infections, Endemic and Emerging Diseases in Populations of Homeless, +15 more
Locations: Assistance Publique Hopitaux de Marseille Marseille, France

View Trial Details

Completed

Follow-up Study of SyB L-0501 in Combination With Rituximab to Treat DLBCL

NCT04354402

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Research Site Nagoya, Aichi-ken, Japan

Research Site Matsuyama, Ehime, Japan

Research Site Ōta, Gunma, Japan

Research Site Fukuyama, Hiroshima, Japan

View all 17 locations

View Trial Details

Completed

Phase III Study of SyB L-0501 in Combination With Rituximab to Treat Recurrent/Relapsed Diffuse Large B-Cell Lymphoma

NCT03372837

Conditions: Assess the Efficacy and Safety of SyB L-0501 in Combination With Rituximab in Patients With Recurrent or Relapsed DLBCL, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Research Site Nagoya, Aichi-ken, Japan

Research Site Toyoake, Aichi-ken, Japan

Research Site Matsuyama, Ehime, Japan

Research Site Maebashi, Gunma, Japan

View all 29 locations

View Trial Details

Completed

Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas

NCT00783367

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +33 more
Locations: University of Pennsylvania; Abramson Cancer Center; Lymphoma Program Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and Rituxan

NCT00496873

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +18 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies

NCT03886831

Conditions: Adenocarcinoma, Adenoid Cystic Carcinoma, Anemia, +39 more
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

UCSF Precision Cancer Medicine Building San Francisco, California, United States

Christiana Care Health Services, Christiana Hospital Newark, Delaware, United States

Florida Cancer Specialists Lake Mary, Florida, United States

View all 23 locations

View Trial Details

Completed

TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia

NCT04323657

Conditions: Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, +20 more
Locations: Colorado Blood Cancer Institute Denver, Colorado, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma

NCT00644189

Conditions: Anaplastic Large-Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Chronic Disease, +35 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Tumor Heterogeneity in Diffuse Large B-cell Lymphoma in Relation to CNS Involvement and Cell-free DNA

NCT04763148

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Department of Hematology, Rigshospitalet Copenhagen, Denmark

View Trial Details

Completed

Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma

NCT03019640

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +17 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Lymphoma, B-Cell

Lymphoma, B-Cell trial results

Related conditions